{"entity":{"type":"insider","cik":"0001284621","url":"/insider/0001284621","json_url":"/insider/0001284621.json","name":"OTTO MICHAEL J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":61,"n_filings":13,"first":"2008-04-04","last":"2017-07-26","span_basis":"filed_date"},"name_variants":[{"name":"OTTO MICHAEL J.","source":"filing","n_filings":7,"first_seen":"2010-09-29","last_seen":"2017-07-26"},{"name":"OTTO MICHAEL","source":"filing","n_filings":6,"first_seen":"2008-04-04","last_seen":"2009-09-21"}],"transactions":[{"id":4710351,"accession":"0001209191-17-046317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-046317","line_url":"/filing/0001209191-17-046317#line-1","is_derivative":false,"issuer_cik":"0001284621","issuer_name":"CONTRAFECT Corp","issuer_ticker":"CFRX","issuer_name_source":null,"issuer_url":"/issuer/0001284621","owner_cik":"0001284621","owner_name":"OTTO MICHAEL J.","owner_display_name":"OTTO MICHAEL J.","owner_url":"/insider/0001284621","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":1.24,"price_display":"1.24","price_state":"stated","total_value":9920.0,"total_display":"9,920.00","total_whole":"9,920","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-25","filed_date":"2017-07-26","scope":"insider"},{"id":9009432,"accession":"0001209191-11-054808","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-054808","line_url":"/filing/0001209191-11-054808#line-2","is_derivative":false,"issuer_cik":"0001284621","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001284621","owner_cik":"0001284621","owner_name":"OTTO MICHAEL J.","owner_display_name":"OTTO MICHAEL J.","owner_url":"/insider/0001284621","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":74.56,"price_display":"74.56","price_state":"stated","total_value":1304800.0,"total_display":"1,304,800.00","total_whole":"1,304,800","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-01","filed_date":"2011-11-07","scope":"insider"},{"id":8926213,"accession":"0001192482-11-000194","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-11-000194","line_url":"/filing/0001192482-11-000194#line-2","is_derivative":false,"issuer_cik":"0001284621","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001284621","owner_cik":"0001284621","owner_name":"OTTO MICHAEL J.","owner_display_name":"OTTO MICHAEL J.","owner_url":"/insider/0001284621","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8929.0,"shares_display":"8,929","price_per_share":119.99,"price_display":"119.99","price_state":"stated","total_value":1071390.71,"total_display":"1,071,390.71","total_whole":"1,071,391","shares_owned_after":7189.0,"shares_owned_after_display":"7,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-01","filed_date":"2011-08-03","scope":"insider"},{"id":8957071,"accession":"0001192482-11-000109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-11-000109","line_url":"/filing/0001192482-11-000109#line-1","is_derivative":false,"issuer_cik":"0001284621","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001284621","owner_cik":"0001284621","owner_name":"OTTO MICHAEL J.","owner_display_name":"OTTO MICHAEL J.","owner_url":"/insider/0001284621","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9500.0,"shares_display":"9,500","price_per_share":99.85,"price_display":"99.85","price_state":"stated","total_value":948575.0,"total_display":"948,575.00","total_whole":"948,575","shares_owned_after":7189.0,"shares_owned_after_display":"7,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-28","filed_date":"2011-04-29","scope":"insider"},{"id":9162342,"accession":"0001192482-11-000086","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-11-000086","line_url":"/filing/0001192482-11-000086#line-2","is_derivative":false,"issuer_cik":"0001284621","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001284621","owner_cik":"0001284621","owner_name":"OTTO MICHAEL J.","owner_display_name":"OTTO MICHAEL J.","owner_url":"/insider/0001284621","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6279.0,"shares_display":"6,279","price_per_share":64.0,"price_display":"64.00","price_state":"stated","total_value":401856.0,"total_display":"401,856.00","total_whole":"401,856","shares_owned_after":16689.0,"shares_owned_after_display":"16,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-22","filed_date":"2011-03-24","scope":"insider"},{"id":7367306,"accession":"0001192482-10-000278","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-10-000278","line_url":"/filing/0001192482-10-000278#line-1","is_derivative":false,"issuer_cik":"0001284621","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001284621","owner_cik":"0001284621","owner_name":"OTTO MICHAEL J.","owner_display_name":"OTTO MICHAEL J.","owner_url":"/insider/0001284621","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":29.5,"price_display":"29.50","price_state":"stated","total_value":147500.0,"total_display":"147,500.00","total_whole":"147,500","shares_owned_after":16689.0,"shares_owned_after_display":"16,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-01","filed_date":"2010-10-01","scope":"insider"},{"id":7304700,"accession":"0001192482-10-000264","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-10-000264","line_url":"/filing/0001192482-10-000264#line-2","is_derivative":false,"issuer_cik":"0001284621","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001284621","owner_cik":"0001284621","owner_name":"OTTO MICHAEL J.","owner_display_name":"OTTO MICHAEL J.","owner_url":"/insider/0001284621","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12811.0,"shares_display":"12,811","price_per_share":29.5,"price_display":"29.50","price_state":"stated","total_value":377924.5,"total_display":"377,924.50","total_whole":"377,925","shares_owned_after":21689.0,"shares_owned_after_display":"21,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-28","filed_date":"2010-09-29","scope":"insider"},{"id":5882545,"accession":"0001192482-09-000271","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001192482-09-000271","line_url":"/filing/0001192482-09-000271","is_derivative":false,"issuer_cik":"0001284621","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001284621","owner_cik":"0001284621","owner_name":"OTTO MICHAEL","owner_display_name":"OTTO MICHAEL","owner_url":"/insider/0001284621","role":"Officer (Exec.VP,Pharm.Research)","role_mark":"O","role_mark_label":"Officer (Exec.VP,Pharm.Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec.VP,Pharm.Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":21.926525,"price_display":"21.93","price_state":"stated","total_value":877061.0,"total_display":"877,061.00","total_whole":"877,061","shares_owned_after":46100.0,"shares_owned_after_display":"46,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-18","filed_date":"2009-09-21","scope":"insider","n_lines":5},{"id":3604647,"accession":"0001192482-08-000262","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001192482-08-000262","line_url":"/filing/0001192482-08-000262","is_derivative":false,"issuer_cik":"0001284621","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001284621","owner_cik":"0001284621","owner_name":"OTTO MICHAEL","owner_display_name":"OTTO MICHAEL","owner_url":"/insider/0001284621","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5835.0,"shares_display":"5,835","price_per_share":21.400956298200516,"price_display":"21.40","price_state":"stated","total_value":124874.58,"total_display":"124,874.58","total_whole":"124,875","shares_owned_after":23835.0,"shares_owned_after_display":"23,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-11","filed_date":"2008-08-13","scope":"insider","n_lines":19},{"id":3964699,"accession":"0001192482-08-000179","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001192482-08-000179","line_url":"/filing/0001192482-08-000179","is_derivative":false,"issuer_cik":"0001284621","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001284621","owner_cik":"0001284621","owner_name":"OTTO MICHAEL","owner_display_name":"OTTO MICHAEL","owner_url":"/insider/0001284621","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81264.0,"shares_display":"81,264","price_per_share":17.51154631817287,"price_display":"17.51","price_state":"stated","total_value":1423058.3,"total_display":"1,423,058.30","total_whole":"1,423,058","shares_owned_after":25961.0,"shares_owned_after_display":"25,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-27","filed_date":"2008-05-29","scope":"insider","n_lines":18},{"id":3737279,"accession":"0001192482-08-000111","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001192482-08-000111","line_url":"/filing/0001192482-08-000111#line-4","is_derivative":false,"issuer_cik":"0001284621","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001284621","owner_cik":"0001284621","owner_name":"OTTO MICHAEL","owner_display_name":"OTTO MICHAEL","owner_url":"/insider/0001284621","role":"Officer (Exec.VP,Pharm.Research)","role_mark":"O","role_mark_label":"Officer (Exec.VP,Pharm.Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec.VP,Pharm.Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":2000.0,"total_display":"2,000.00","total_whole":"2,000","shares_owned_after":19500.0,"shares_owned_after_display":"19,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-07","filed_date":"2008-04-08","scope":"insider"}],"collapsed":true,"next_cursor":"2008-04-07|3737279","ledger_fault":false,"count":{"value":61,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":60,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":61},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001478069","name":"CONTRAFECT Corp","url":"/issuer/0001478069","role":"Director","n_filings":1,"first_seen":"2017-07-26","last_seen":"2017-07-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001301081","name":"Pharmasset Inc","url":"/issuer/0001301081","role":"Officer (Chief Scientific Officer)","n_filings":12,"first_seen":"2008-04-04","last_seen":"2011-11-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001284621","retrieved_at":"2026-08-24T08:35:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}